Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
OVID holding history
Ovid Therapeutics Inc. in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OVID overviewAll 13F holders of OVIDFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,115,538
- Value
- $3.00M
- % of portfolio
- 1.6%
- Quarters held
- 2
- Since Q1 2026